Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 2, 2009, Pages 151.e1-151.e9

  Kahn, Susan R ^a   Platt, Robert ^a   McNamara, Helen ^a   Rozen, Rima ^a   Chen, Moy Fong ^a   Genest Jr , Jacques ^a   Goulet, Lise ^b   Lydon, John ^c   Seguin, Louise ^b   Dassa, Clement ^b   Masse, André ^b   Asselin, Guylaine ^b   Benjamin, Alice ^a   Miner, Louise ^a   Ghanem, Antoinette ^b   Kramer, Michael S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

factor V Leiden; folate; hyperhomocysteinemia; placental pathology; preeclampsia; prothrombin gene mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; FOLIC ACID; HOMOCYSTEINE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; THROMBOPHILIA;

EID: 58749116983     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.09.023     Document Type: Article

References (43)

1. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
3. Kaunitz A.M., Hughes J.M., Grimes D.A., et al. Causes of maternal mortality in the United States, 1979-1986. Am J Obstet Gynecol 163 (1990) 460-465
4. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 99 (1992) 547-553
5. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 (2005) 565
6. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
7. Rosendaal F.R., Koster T., Vanderbroucke J.P., and Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden. Blood 85 (1995) 1504-1508
8. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
9. Frost P., Bloom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
10. Jacques P.F., Bostom A.G., Williams R.R., et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
11. den Heijer M., Blom H.J., Gerrits W.B.J., et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?. Lancet 345 (1995) 882-885
12. Ridker P.M., Hennekens C.H., Selhub J., Miletich J.P., Malinow M.R., and Stampfer M.J. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95 (1997) 1777-1782
13. Eikelbloom J.W., Lonn E., Genest J., Hankey G., and Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of epidemiologic evidence. Ann Intern Med 131 (1999) 363-375
14. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
15. Kupferminc M.J., Eldor A., Steinman N., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340 (1999) 9-13
16. Dizon-Townson D.S., Helson L.N., Easton K., and Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175 (1996) 902-905
17. Grandone E., Margaglione M., Colaizzo D., et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77 (1997) 1052-1054
18. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
19. Middeldorp S. Thrombophilia and pregnancy complications: cause or association?. J Thromb Haemost 5 (2007) 276-282
20. Kramer M.S., Goulet L., Lydon J., et al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 15 Suppl2 (2001) 104-123
21. Helewa M.E., Burrows R.F., Smith J., Williams K., Brain P., and Rabkin S.W. 1: definitions, evaluation and classification of hypertensive disorders in pregnancy. Can Med Assoc J 157 (1997) 715-725
22. Dekker G.A., de Vries J.I.P., Doelitzsch P.M., et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 173 (1995) 1042-1048
23. Kramer M.S., Chen M.F., Roy I., et al. Intra- and interobserver agreement and statistical clustering of placental histopathologic features relevant to preterm birth. Am J Obstet Gynecol 195 (2006) 1674-1679
24. Statistics Canada. Low income cut-offs. Catalogue 13-551-XIB, Dec. 1999. Ottawa, Canada.
25. Breslow N.E., and Day N.E. The design and analysis of cohort studies. Statistical methods in cancer research. Vol II (1987), IARC Scientific Publications, Lyon
26. Dizon-Townson D., Miller C., Sibai B., et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 106 (2005) 517-524
27. Kocher O., Cirovic C., Malynn E., et al. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients. Am J Clin Pathol 127 (2007) 68-75
28. March R.E. Gene mapping by linkage and association analysis. Mol Biotechnol 13 (1999) 113-122
29. Robertson L., Wu O., Langhorne P., et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
30. Morrison E.R., Miedzybrodzka Z.H., Campbell D.M., et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 87 (2002) 779-785
31. Murphy R.P., Donoghue C., Nallen R.J., et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 20 (2000) 266-270
32. Lin J., and August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
33. Salafia C.M., Pezzullo J.C., López-Zeno J.A., Simmens S., Minior V.K., and Vintzileos A.M. Placental pathological features of preterm preeclampsia. Am J Obstet Gynecol 173 (1995) 1097-1105
34. Mousa H.A., and Alfirevic1 Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod 15 (2000) 1830-1833
35. Steegers-Theunissen R.P.M., Smith S.C., Steegers E.A.P., Guilbert L.J., and Baker P.N. Folate affects apoptosis in human trophoblastic cells. BJOG 107 (2000) 1513-1515
36. Di Simone N., Riccardi P., Maggiano N., et al. Effect of folic acid on homocysteine-induced trophoblast apoptosis. Mol Hum Reprod 10 (2004) 665-669
37. Sanchez S.E., Zhang C., Malinow M.R., Ware-Jauregui S., Larrabure G., and Williams M.A. Plasma folate, vitamin B12, and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol 153 (2001) 474-480
38. Rajkovic A., Mahomed K., Rozen R., Malinow M.R., King I.B., and Williams M.A. Methylenetetrahydrofolate reductase 677 C → T polymorphism, plasma folate, vitamin b12 concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metab 69 (2000) 33-39
39. Chalmers B., Dzakpasu S., Heaman M., and Kaczorowski J. The Canadian maternity experiences survey: an overview of findings. J Obstet Gynaecol Can 30 (2008) 217-228
40. Gerhardt A., Goecke T.W., Beckmann M.W., et al. the G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia. J Thromb Haemost 3 (2005) 686-691
41. Skjaerven R., Vatten L.J., Wilcox A.J., Ronning T., Irgens L.M., and Lie R.T. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 331 (2005) 877
42. Rodger M.A., Paidas M., McLintock C., et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112 2Pt1 (2008) 320-324
43. Kramer M.S., Platt R.W., Wen S.W., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108 (2001) E35